Physician profile
Collin B Sutton
NPI 1114226925
$9,994.55
in general payments reported to CMS, 2019-2025
28 companies · $1,355 in 2025
The $1,355 reported for 2025 was more than what 85% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,025 · 2020: $766 · 2021: $1,560 · 2022: $1,052 · 2023: $657 · 2024: $2,579 · 2025: $1,355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,929 · Travel and Lodging: $1,564 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,929.22 |
| Travel and Lodging | $1,563.82 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $2,179.90 | 2019-2024 | Trudi Nav Cable, Acclarent Navwire |
| Medtronic USA, INC. | $1,968.41 | 2019-2020 | |
| Aerin Medical INC. | $1,161.35 | 2019-2025 | |
| Medtronic, INC. | $1,034.27 | 2021-2025 | Propel, Nuvent, Pteye Parathyroid Detection System |
| Optinose US, INC. | $688.05 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $612.34 | 2019-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $409.84 | 2021-2025 | |
| Neurent Medical Limited | $309.06 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Glaxosmithkline, LLC. | $228.17 | 2022-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Stryker Corporation | $208.55 | 2023-2025 | Scopis Ent, Xpress Loprofile, Clarifix Cryotherapy Device |
| Integra Lifesciences Corporation | $202.83 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Alk-Abello, INC | $187.86 | 2019-2022 | |
| Inspire Medical Systems, INC. | $122.13 | 2025 | Inspire |
| Abbvie INC. | $117.94 | 2021-2024 | |
| Intersect Ent, INC. | $85.15 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $70.72 | 2019-2025 | |
| Kaleo, INC. | $64.54 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $57.59 | 2019 | |
| Spirair, INC. | $54.19 | 2025 | |
| Olympus America INC. | $54.00 | 2019 | |
| Merck Sharp & Dohme LLC | $34.59 | 2021-2023 | |
| Ars Pharmaceuticals Operations, INC. | $28.52 | 2025 | Neffy |
| Phathom Pharmaceuticals, INC. | $27.18 | 2024 | Voquezna |
| Amgen INC. | $20.44 | 2025 | Tezspire |
| Pfizer INC. | $19.31 | 2024 | |
| Aytu Biopharma, INC. | $17.36 | 2025 | |
| Hikma Pharmaceuticals USA | $16.38 | 2023 | Ryaltris |
| Azurity Pharmaceuticals, INC. | $13.88 | 2025 | Alvesco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collin Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.